USAF HPSP pitfalls
After spending 13 years enlisted, 8 of it AD, in aviation maintenance I entered a US MD program on an HPSP scholarship. During April of my second year I was diagnosed with NHL after presenting with back pain and pending paraplegia. I underwent an emergent laminectomy followed by EBRT and chemotherapy. January of my fourth year I was notified that my scholarship was being terminated for being unfit to serve. I was never allowed to meet a medical board. I graduated with my class and completed... Read more (Source: Student Doctor Network)
Source: Student Doctor Network - February 17, 2024 Category: Universities & Medical Training Authors: MT Doc Tags: Military Medicine Source Type: forums

Chemotherapy-related side effects: Accommodations in Med school?
Hi everyone, Does anyone have experience with or knowledge pertaining to requesting accommodations at med school specific to the side effects of chemotherapy? e.g. chemo brain / brain fog, intermittent fatigue, delayed recall, reduced attention/ concentration, etc. Do you know if med schools tend to provide accommodations for these type of cancer treatment-related side effects? Is this a difficult process? How extensive of documentation is required? I'm coming off treatment soon and due... Read more (Source: Student Doctor Network)
Source: Student Doctor Network - December 4, 2023 Category: Universities & Medical Training Authors: Curlywhirly1 Tags: Medical Students (MD) Source Type: forums

realistic near future breakthroughs in neurointervention!
1) possibility of repeating the success of retinoblastoma intra arterial chemotherapy to brain gliomas as standalone curative therapy either by chemo or nano, immune,etc 2) endovascular brain computer interface, how far from being a real alternative to biological solutions for diseases like spinal cord injury , retinal dystophy , hearing loss 3) drawbacks of the neurology route to INR 4) most realistic near future breakthroughs in this field other than hydrocephaly stent , ICH,LVO... Read more (Source: Student Doctor Network)
Source: Student Doctor Network - November 20, 2023 Category: Universities & Medical Training Authors: khaled salah Tags: Neurology Source Type: forums

Chemotherapy induced peripheral neuropathy
88yo with h/o chemotherapy induced neuropathy in BLE. Tried gabapentin, duloxtine, lyrica, topamax, ALA, topical lido/voltaren/menthol/capsaicin, TENS. Pt not interested in SCS, worried about sedation. Lives alone and also given age, I've tried to hold off on TCAs...but I may need to go that route as pain is worsening. What else can I offer? LESI?? (Source: Student Doctor Network)
Source: Student Doctor Network - August 22, 2023 Category: Universities & Medical Training Authors: oneforfighting Tags: Pain Medicine Source Type: forums

Chemotherapy + Orgo 1?
Would love some advice. Been hearing horror stories about it my entire freshman year and I was unconfident of doing good in it before my cancer diagnosis. The chemotherapy is set to end September 3rd, and my orgo class starts early August. I looked at the syllabus and apparently I will be under chemo for effectively 25% of the course (the first exam is on September 15th). Doctor said I have a pretty aggressive chemotherapy regimen (it’s something called GC), and my performance entirely... Read more (Source: Student Doctor Network)
Source: Student Doctor Network - April 12, 2023 Category: Universities & Medical Training Authors: Round786 Tags: Pre-Medical (MD) Source Type: forums

Rapido
radmonckey said: RAPIDO was an unbalanced trial with much less systemic therapy given in the SOC arm, yet LC still "favored" long course. I'll see what I want to see View attachment 344624 Click to expand... Locoregional Failure During and After Short-course Radiotherapy followed by Chemotherapy and Surgery Compared to Long-course Chemoradiotherapy and Surgery - A Five-year Follow-up of the RAPIDO Trial - PubMed The EXP treatment was associated with an increased...
Source: Student Doctor Network - January 22, 2023 Category: Universities & Medical Training Authors: radmonckey Tags: Radiation Oncology Source Type: forums

No more PMRT for cN1 ypN0 breast cancer?
De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study​ Background​Primary chemotherapy in breast cancer poses a dilemma with regard to adjuvant locoregional radiotherapy, as guidelines for locoregional radiotherapy were originally based on pathology results of primary surgery. We aimed to evaluate the oncological safety of de-escalated locoregional... Read more (Source: Student Doctor Network)
Source: Student Doctor Network - September 3, 2022 Category: Universities & Medical Training Authors: TheWallnerus Tags: Radiation Oncology Source Type: forums

Chemotherapy Treatment Assessments
Interested in how often others in practice see patients on infusion chemotherapy regimens (not oral therapy). Do you see patients before every treatment as an E&M encounter? Do you see every 4 weeks for every 2 week regimens? Interested in others experiences. (Source: Student Doctor Network)
Source: Student Doctor Network - May 16, 2022 Category: Universities & Medical Training Authors: guildsman Tags: Hematology / Oncology Source Type: forums

Medical Supplies
Hello! I have a family member who came from oversees and needs some medical supplies to take back home due to a shortage in our country. He needs IV fluids and kits for administration of IV fluids but no meds (he is receiving chemotherapy). Can I order those through one of these medical equipment websites using my license or will I get in trouble for that? Thanks for your help! (Source: Student Doctor Network)
Source: Student Doctor Network - February 17, 2022 Category: Universities & Medical Training Authors: Maryvirginia12 Tags: General Residency Issues Source Type: forums

Re: Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial
(Source: BMJ Comments)
Source: BMJ Comments - December 20, 2021 Category: General Medicine Source Type: forums

Why don ’t we just start giving our own?
Dermpath didn’t ask pathology if it was ok to read skin cancers. Gastroenterologists didn’t ask surgeons if they could do colonoscopies. Neurologists didn’t ask if they could give TMZ. IR didn’t get permission to steal dozens of procedures and form their own specialty. Why don’t we just start giving radiosensitizing chemotherapy as part of our training. That could open the door to other systemic agents and then maybe we could work our way up from the bottom of the food chain and become a... Read more (Source: Student Doctor Network)
Source: Student Doctor Network - September 18, 2021 Category: Universities & Medical Training Authors: Bequerel Tags: Radiation Oncology Source Type: forums

Resource for surveillance imaging standard protocols following surgery/chemotherapy/radiotherapy?
I was looking through ASCO and ACS with regards to any information pertaining to surveillance imaging recommendations for various cancer types after treatment (surgery, radiotherapy, chemotherapy). I understand that factors such as location and cell type or other markers complicate this and therefore each cancer type is unique. I was able to only find a few guideline articles listed as "current" for maybe 4 or 5 frequently diagnosed cancers. I was curious if any single organization or... Read more (Source: Student Doctor Network)
Source: Student Doctor Network - September 15, 2021 Category: Universities & Medical Training Authors: bengalsfan0525 Tags: Hematology / Oncology Source Type: forums

Breast is the worst: another case!
42 year old healthy female diagnosed with a huge DCIS , received mastectomy and sentinel lymph node dissection. Inside the 11cm big DCIS, 2 invasive ductal carcinomas were found, biggest one was 2.2cm in diameter. Axillary status is pN1 with a micrometastasis in 1 / 3 nodes (0.5 mm), no ECE. Reconstruction was performed with an implant. Oncotype Dx score is 12, so no chemotherapy. So, it's a pT2(m) pN1 (1/3mi) cM0 L0 V0 Pn0 R0 ER100% PR10% Her2- G2 invasive ductal carcinoma. Looking... Read more (Source: Student Doctor Network)
Source: Student Doctor Network - June 30, 2021 Category: Universities & Medical Training Authors: Palex80 Tags: Radiation Oncology Source Type: forums

Logic behind different concurrent chemotherapy regimens
Hello everyone, As I'm studying for boards (on GI cancers now), I have been noticing the plethora of concurrent chemotherapy regimens that have been tried over the years and I'm trying to make sense of this information. As general rules of thumb, do we expect certain concurrent chemotherapy regimens to work better in adenocarcinoma compared to SCC or vice versa? (5FU/cisplatin/carboplatin/etoposide/xeloda/epirubicin/leucovorin) For example, why would you treat both SCC and... Read more (Source: Student Doctor Network)
Source: Student Doctor Network - March 8, 2021 Category: Universities & Medical Training Authors: TurboTesla Tags: Radiation Oncology Source Type: forums

Breast SIB
Anybody ever SIB a worrisome axillary level 2 node following mastectomy with 4/19 level 1 nodes. Plus/minus on whether the patient would be willing to undergo further resection, and has already said no to adjuvant chemotherapy. I'm just wondering about an sib if all other avenues are blocked. (Source: Student Doctor Network)
Source: Student Doctor Network - January 31, 2021 Category: Universities & Medical Training Authors: Ray D. Ayshun Tags: Radiation Oncology Source Type: forums